Katarína Kľučková

2.8k total citations
16 papers, 514 citations indexed

About

Katarína Kľučková is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Katarína Kľučková has authored 16 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Katarína Kľučková's work include Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (5 papers) and ATP Synthase and ATPases Research (3 papers). Katarína Kľučková is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (5 papers) and ATP Synthase and ATPases Research (3 papers). Katarína Kľučková collaborates with scholars based in United Kingdom, Australia and Czechia. Katarína Kľučková's co-authors include Jiřı́ Neužil, Lan‐Feng Dong, Jakub Rohlena, Daniel A. Tennant, Gareth G. Lavery, Jacob Goodwin, Melanie Penke, Wieland Kieß, Antje Garten and Maria Nguyen and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

In The Last Decade

Katarína Kľučková

16 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarína Kľučková United Kingdom 11 334 242 61 54 46 16 514
Chenfei Huang China 14 391 1.2× 196 0.8× 42 0.7× 44 0.8× 95 2.1× 19 615
Marcela Sosa‐Garrocho Mexico 12 341 1.0× 170 0.7× 38 0.6× 25 0.5× 77 1.7× 23 507
Yajie Zhao China 11 285 0.9× 249 1.0× 67 1.1× 109 2.0× 100 2.2× 28 509
Muhammad Tufail China 14 315 0.9× 174 0.7× 39 0.6× 74 1.4× 125 2.7× 57 608
Shaoyan Jiang China 13 335 1.0× 225 0.9× 48 0.8× 45 0.8× 27 0.6× 20 496
William Twaddel United States 4 379 1.1× 236 1.0× 56 0.9× 33 0.6× 67 1.5× 4 501
Bor Jang Hwang United States 4 379 1.1× 236 1.0× 56 0.9× 33 0.6× 67 1.5× 4 501

Countries citing papers authored by Katarína Kľučková

Since Specialization
Citations

This map shows the geographic impact of Katarína Kľučková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarína Kľučková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarína Kľučková more than expected).

Fields of papers citing papers by Katarína Kľučková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarína Kľučková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarína Kľučková. The network helps show where Katarína Kľučková may publish in the future.

Co-authorship network of co-authors of Katarína Kľučková

This figure shows the co-authorship network connecting the top 25 collaborators of Katarína Kľučková. A scholar is included among the top collaborators of Katarína Kľučková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarína Kľučková. Katarína Kľučková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
D’Avola, Annalisa, Nathalie Legrave, Mylène Tajan, et al.. (2024). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation. 134(4). 1 indexed citations
2.
D’Avola, Annalisa, Katarína Kľučková, Andrew J. Finch, & John C. Riches. (2023). Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers. OncoTargets and Therapy. Volume 16. 371–383. 7 indexed citations
3.
D’Avola, Annalisa, Nathalie Legrave, Mylène Tajan, et al.. (2022). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.. Figshare. 25 indexed citations
4.
Kľučková, Katarína, Annalisa D’Avola, & John C. Riches. (2022). Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy. Cancers. 14(22). 5552–5552. 8 indexed citations
5.
Kľučková, Katarína, Andrew Clear, Annalisa D’Avola, et al.. (2022). B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities. HemaSphere. 6(6). e722–e722. 11 indexed citations
6.
Moog, Sophie, Aurélie Morin, Géraldine Gentric, et al.. (2021). Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate. Cancer Research. 81(13). 3480–3494. 40 indexed citations
7.
Garten, Antje, et al.. (2019). Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1. International Journal of Molecular Sciences. 20(16). 4048–4048. 70 indexed citations
8.
Kľučková, Katarína, Alpesh Thakker, Lisa A. Vettore, et al.. (2019). Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase function. The FASEB Journal. 34(1). 303–315. 20 indexed citations
9.
Kľučková, Katarína & Daniel A. Tennant. (2018). Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma. Cell and Tissue Research. 372(2). 367–378. 40 indexed citations
10.
Truksa, Jaroslav, Lan‐Feng Dong, Jakub Rohlena, et al.. (2015). Mitochondrially Targeted Vitamin E Succinate Modulates Expression of Mitochondrial DNA Transcripts and Mitochondrial Biogenesis. Antioxidants and Redox Signaling. 22(11). 883–900. 38 indexed citations
11.
Kľučková, Katarína, Lan‐Feng Dong, Martina Bajzíková, Jakub Rohlena, & Jiřı́ Neužil. (2015). Evaluation of Respiration of Mitochondria in Cancer Cells Exposed to Mitochondria-Targeted Agents. Methods in molecular biology. 1265. 181–194. 2 indexed citations
12.
Tomasetti, Marco, Linda Nocchi, Sara Staffolani, et al.. (2014). MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with the Mitochondrial Function. Antioxidants and Redox Signaling. 21(15). 2109–2125. 81 indexed citations
13.
Mráček, Tomáš, Hana Nůsková, Marek Vrbacký, et al.. (2013). High Molecular Weight Forms of Mammalian Respiratory Chain Complex II. PLoS ONE. 8(8). e71869–e71869. 7 indexed citations
14.
Procházka, Lubomír, Štěpán Koudelka, Lan‐Feng Dong, et al.. (2013). Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to α-tocopheryl succinate. APOPTOSIS. 18(3). 286–299. 32 indexed citations
15.
Kľučková, Katarína, et al.. (2012). Mitochondrial complex II, a novel target for anti-cancer agents. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1827(5). 552–564. 91 indexed citations
16.
Rohlena, Jakub, Lan‐Feng Dong, Katarína Kľučková, et al.. (2011). Mitochondrially Targeted α-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing. Antioxidants and Redox Signaling. 15(12). 2923–2935. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026